CanSino Biologics, Inc. (CASBF)
3.86
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
CanSino Biologics EPS Diluted (Quarterly) : -0.0236 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sinovac Biotech Ltd. | -- |
| CASI Pharmaceuticals, Inc. | -0.6781 |
| Zai Lab Ltd. | -0.4621 |
| Ascletis Pharma, Inc. | -- |
| CStone Pharmaceuticals Co. Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.838M |
| Revenue (Quarterly) | 27.48M |
| Total Expenses (Quarterly) | 33.32M |
| Enterprise Value | 820.45M |
| Gross Profit Margin (Quarterly) | 80.94% |
| Profit Margin (Quarterly) | -21.24% |
| Earnings Yield | -0.03% |
| Normalized Earnings Yield | -0.0751 |